PETVIVO HOLDINGS, INC. ANOUNCES LAUNCH OF NEW COMPANY AND PRODUCT WEBSITES
March 07 2022 - 7:00AM
PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an
emerging biomedical device company focused on the commercialization
of innovative medical devices and therapeutics for pets announced
today the launch of two new website; the first exhibiting the
Company and the second exhibiting PetVivo’s current product Spryng™
with OsteoCushion™ Technology. Each website went live on March 4,
2022. The new websites offer a clean, modern design, easy
navigation and helpful tools and resources to be utilized by
everyone looking to learn more about PetVivo and its products.
Through this launch and future growth of these new company and
product websites, PetVivo strives as an industry leader to deliver
consistent, relevant information, news and other resources you can
use daily.
“We are thrilled to launch these new websites
and strongly feel it will serve as a useful, informative portal for
companion animal owners, veterinarians and others looking to gain a
better understanding of PetVivo, our innovative product, Spryng,
and all that we have to offer,” said John Lai, Chief Executive
Officer of PetVivo Holdings, Inc. ”I feel that these new websites
properly align with our company vision for growth and expansion in
the future.”
The purpose behind the new look and feel of the
PetVivo company website is to better provide innovative resources
and information to veterinarians, companion animal owners, as well
as existing and potential investors, covering product information,
news releases, product information and other general company
information. The website will highlight all of the tools and
resources available at the click of a button and make evident that
PetVivo is at the forefront of industry trends and technology. The
new PetVivo company website can be accessed at www.petvivo.com
Additionally, the purpose behind the launch of
the Spryng product website is to better provide educational product
information directed to veterinarians as well as companion animal
owners. The website will highlight comprehensive information
regarding product composition and use of Spryng, case studies and
scientific information demonstrating the benefits of the product,
as well as a portal for ordering and purchase of Spryng. The Spryng
product website can be accessed at www.sprynghealth.com.
PetVivo’s innovative therapeutic product, Spryng
with OsteoCushion Technology, is a veterinary medical device
comprised of millions of micronized hydrogel matrices, which are
derived from natural components, collagen and elastin. OsteoCushion
Technology provides both reinforcing natural joint support to
replace and/or reinforce missing and damaged cartilage, as well as
delivers natural scaffolding to help address tissue defects. These
attributes offer a great solution to manage lameness and joint
afflictions, such as osteoarthritis, for companion animals in a
simple in-clinic treatment.
For more information about PetVivo Holdings,
Inc. please contact info1@petvivo.com or visit
https://petvivo.com/
About PetVivo
Holdings, Inc.
PetVivo Holdings Inc. (NASDAQ: PETV) is an
emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG, a
veterinarian-administered, intraarticular injection for the
treatment of lameness and other joint related afflictions,
including osteoarthritis, in dogs and horses, is currently
available for commercial sale to veterinarians.
CONTACT:
John Lai, CEOPetVivo Holdings, Inc.Email:
info1@petvivo.com(952) 405-6216
Forward-Looking commercial
Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements,
including the potential listing of the Company’s common stock on
Nasdaq, are based on information currently available the Company
and its current plans or expectations and are subject to a number
of uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2021 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
PetVivo (NASDAQ:PETVW)
Historical Stock Chart
From Aug 2024 to Sep 2024
PetVivo (NASDAQ:PETVW)
Historical Stock Chart
From Sep 2023 to Sep 2024